Study of GC101 TIL in Brain Glioma (Soochow2)
Clinical trial NCT04943913 · RECRUITING
Trial details
- NCT number
- NCT04943913
- Sponsor
- Shanghai Juncell Therapeutics
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2026-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.